October 15, 2019
French health tech startup Primaa has raised €2m to accelerate the development and the international marketing of its automated diagnostic products.
The Paris-based firm, founded in 2018, develops software tools which use artificial intelligence (AI) and deep learning to assist anatomical pathologists with cancer and other diagnoses.
It is currently in the process of finalising its first tool...
Kheiron founders Dr Peter Kecskemethy and Tobias Rijken (left to right)
September 25, 2019
Kheiron Medical Technologies, a startup that aims to help radiologists detect breast cancer earlier by using deep learning, has announced this week the closing of a $22m Series A round led by London-headquartered VC firm Atomico. Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds, existing backers, also participated.
WHAT THEY DO
The startup was founded in 2016 by Peter Kecskemethy and...
March 8, 2018
The Mayo Clinic has just released the results of a new study, which show an 80 percent increase in enrollment of clinical trials for breast cancer when using IBM’s Watson for Clinical Trial matching system.
The Watson system uses artificial intelligence to analyze unstructured information and pull out insights from the data.
“Watson is able to give us faster, better matching of patients to...
October 11, 2017
Patient, provider atrial fibrillation apps launch. Two new smartphone and tablet apps targeting atrial fibrillation and designed by the European Society of Cardiology (ESC) and the University of Birmingham have launched for free on the iOS App Store and Google Play store. My AF provides patients with information about the condition, treatments, and tips on improving lifestyle, and allows patients...
November 30, 2015
The Apple Watch pilot that the MD Anderson Cancer Center at Cooper announced last May finally launched today. In collaboration with Wayne, Pennsylvania-based behavioral health technology company Polaris Health Directions, the cancer center is distributing 30 Apple Watches to patients in various stages of treatment for breast cancer.
"May through September was a lot of engineering the application...
September 30, 2015
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
April 21, 2014
The Smart Bra concept from First Warning's 2012 YouTube video.
First Warning Systems, the Reno, Nevada-based company that's working on wearable sensors for early detection of breast cancer, has raised $560,000, according to CEO Rob Royea. Steven Welch, a private investor and former COO of BP (not to be confused with DreamIt Health founder Steve Welch) led the round with a $300,000 contribution...
July 28, 2011
Dr. Brigitte Piniewski is convinced that mobile and wireless technologies can bring the kinds of improvements in population health that policymakers can only dream of. "I really think that's where the vision is at," she says.
Two weeks ago at the eighth annual Healthcare Unbound conference in San Diego, Piniewski said that the biggest trend she's seeing in mobile and wireless health is...
July 28, 2009
The way that we listen to music these days is completely different from the way it used to be; the way we communicate via electronic messaging is also very different; so is the way we read books thanks to devices like Amazon's Kindle, explained The West Wireless Health Institute's Dr. Eric Topol at the Qualcomm Smart Services Summit in San Diego this morning.
"Wouldn't it be natural -- knowing...
April 4, 2009
During his keynote at CTIA, Scripps Health's Dr. Eric Topol outlined a top ten list for conditions and diseases that are already benefiting from wireless health services or soon will. Here's Topol's Top Ten (in alphabetical order) with a figure of the number of Americans affected by each condition or disease. Did he miss any notable opportunities?
Top Ten Targets for Wireless Medicine